Amwell

The project represents Amwell (NYSE: AMWL), a prominent publicly traded telehealth company with significant market presence, verified revenue (~$250M+), and a large team (~3000). While the submission text itself is low-effort and contains hyperbolic claims ('everyone', 'most people have used my product'), the underlying entity demonstrates exceptional real-world utility and verified traction that far exceeds the calibration baseline. The score reflects the massive scale and utility of the platform, penalized slightly only by the poor quality of the submission responses and current market stagnation in the telehealth sector.